Industry Outlook

The contrast media injectors market is set to reach US$ 1155.5 Mn by 2029 from US$ 641.49 Mn in 2020 projecting stable growth at a compounded annual growth rate (CAGR) of 6.8% during the forecast period from 2021 to 2029. Minimal invasive surgeries equipped with contrast media injectors have grabbed prominence in the last 2 decades on account of factors such as increasing number of patients suffering with chronic diseases and rising public health awareness resulting in enhanced preliminary diagnosis.

The advantages associated with contrast media injectors are they provide real time imaging of surgical site and guides the surgeons to conduct safe surgeries of vital organs. The limitations associated with the market growth of contrast media injectors are frequent product recalls and delayed regulatory approvals from healthcare agencies throughout the globe.

"Injector systems to dominate the product segment on account of rising demand for computed tomography (CT) and magnetic resonance imaging (MRI)"

Injector systems are leading the product segment owing to chief factors such as increasing number of outpatients visiting hospitals to perform preliminary diagnosis and steady rise in the number of clinics and research centers housing well-equipped imaging devices such as computed tomography (CT) scans and magnetic resonance imaging (MRI) etc. Technological advancement in the injector systems has drastically reduced human error and provides high accuracy & efficiency. Consumables will be the fastest growing product segment due to availability of diverse range of tubings and syringes at affordable prices and rapid use of imaging devices results in frequent replacement of consumables to alert physicians of potential hazards such as extravasations and air embolism.

"Increasing number of patients suffering with cardiovascular diseases to create a positive traction for interventional cardiology market growth"

Interventional cardiology holds the largest market in application segment on account of factors such as rising prevalence of cardiac disorders and increasing demand for visually guided minimal invasive cardiac surgeries. According to World Health Organization (WHO) statistics, annually 17.9 million people die from cardiovascular disease throughout the globe. The major factors responsible for this high mortality are ineffective diagnosis and delayed medical intervention. Radiology will foster exemplary growth during the forecast period owing to prime factors such as increasing number of traumatic and non-traumatic cases throughout the globe and increasing demand for preliminary diagnosis to determine disease etiology and associated treatment regimen.

"Well-developed healthcare infrastructure to drive the contrast media injectors market in North America"

In the current scenario North America is the leader in the contrast media injectors market with 38% share. The key factors that define its dominance are rising prevalence of chronic diseases and well developed healthcare infrastructure. Domicile of key players such as GE Healthcare and VIVID IMAGING cater the requirement of injector systems for interventional cardiology and radiology. Increasing public health awareness resulting in early diagnosis favors contrast media injectors market growth in North America. In Europe the market growth is driven by increased funding in the research and development of consumables pertaining to contrast media injectors. Healthcare institutions heavily rely upon use of CT scan and MRI for the diagnosis of diseases which serves as a lucrative market for the consumables employed in contrast media injector systems. Asia Pacific will register steady growth during the forecast period on account of key factors such as increasing number of traumatic incidents requiring visual guided surgeries and rapid installation of medical imaging equipment in hospitals and clinics.

Market assessment is an important tool to understand the existing trends in the contrast media injectors market. Technical innovations pertaining to syringes, injectors, tubing’s etc. are covered in the scope of the report. Merger & acquisition and strategic collaboration among key players are covered by studying the organic and inorganic market growth strategies. The key players manufacturing contrast media injector systems and consumables are APOLLO RT Co., Ltd., Sino Medical-Device Technology Co., Ltd, Bayer Healthcare LLC, GE Healthcare, Guerbet Group, Medtron AG, VIVID IMAGING, Nemoto Kyorindo Co., Ltd., Bracco Group and Ulrich GmbH & Co., KG.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Contrast Media Injectors market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Contrast Media Injectors market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Contrast Media Injectors market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Contrast Media Injectors market?
• Which is the largest regional market for Contrast Media Injectors market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Contrast Media Injectors market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Contrast Media Injectors market worldwide?